Evidence map›Paper›PMID 38045693›Full record

ArticleFrontiers in immunology2023

Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology.

Hanna F Nowotny, Thomas Marchant Seiter, Jing Ju, Adrian Gottschlich, Holger Schneider, Stephanie Zopp, Frederick Vogel, Lea Tschaidse, Matthias K Auer, Christian Lottspeich and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The danger theory of immunity revisited.Nature reviews. Immunology · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Hanna F NowotnyDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Thomas Marchant SeiterDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Jing JuDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Adrian GottschlichDivision of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Holger SchneiderDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Stephanie ZoppDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Frederick VogelDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Lea TschaidseDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Matthias K AuerDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Christian LottspeichDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Sebastian KoboldDivision of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Simon RothenfusserDivision of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
Felix BeuschleinDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Martin ReinckeDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Leah BraunDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Nicole ReischDepartment of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Ludwig-Maximilians-Universität München · DELMU Klinikum · DEDeutschen Konsortium für Translationale Krebsforschung · DEHelmholtz Zentrum München · DE

Funding

European Research Council 756017
6 · The paper itself

Abstract

Introduction: Patients with primary adrenal insufficiency (PAI) suffer from increased risk of infection, adrenal crises and have a higher mortality rate. Such dismal outcomes have been inferred to immune cell dysregulation because of unphysiological cortisol replacement. As the immune landscape of patients with different types of PAI has not been systematically explored, we set out to immunophenotype PAI patients with different causes of glucocorticoid (GC) deficiency. Methods: This cross-sectional single center study includes 28 patients with congenital adrenal hyperplasia (CAH), 27 after bilateral adrenalectomy due to Cushing's syndrome (BADx), 21 with Addison's disease (AD) and 52 healthy controls. All patients with PAI were on a stable GC replacement regimen with a median dose of 25 mg hydrocortisone per day. Peripheral blood mononuclear cells were isolated from heparinized blood samples. Immune cell subsets were analyzed using multicolor flow cytometry after four-hour stimulation with phorbol myristate acetate and ionomycin. Natural killer (NK-) cell cytotoxicity and clock gene expression were investigated. Results: The percentage of T helper cell subsets was downregulated in AD patients (Th1 p = 0.0024, Th2 p = 0.0157, Th17 p < 0.0001) compared to controls. Cytotoxic T cell subsets were reduced in AD (Tc1 p = 0.0075, Tc2 p = 0.0154) and CAH patients (Tc1 p = 0.0055, Tc2 p = 0.0012) compared to controls. NKCC was reduced in all subsets of PAI patients, with smallest changes in CAH. Degranulation marker CD107a expression was upregulated in BADx and AD, not in CAH patients compared to controls (BADx p < 0.0001; AD p = 0.0002). In contrast to NK cell activating receptors, NK cell inhibiting receptor CD94 was upregulated in BADx and AD, but not in CAH patients (p < 0.0001). Although modulation in clock gene expression could be confirmed in our patient subgroups, major interindividual-intergroup dissimilarities were not detected. Discussion: In patients with different etiologies of PAI, distinct differences in T and NK cell-phenotypes became apparent despite the use of same GC preparation and dose. Our results highlight unsuspected differences in immune cell composition and function in PAI patients of different causes and suggest disease-specific alterations that might necessitate disease-specific treatment.

Indexed as

Addison DiseaseAdrenal Hyperplasia, CongenitalAdrenal InsufficiencyCushing SyndromeCross-Sectional StudiesGlucocorticoidsHumansHydrocortisoneLeukocytes, MononuclearGlucocorticoidsHydrocortisoneACTHAddison’s diseasebilateral adrenalectomycongenital adrenal hyperplasiacortisolimmunophenotypeprimary adrenal insufficiency

Identifiers

PMID38045693
PMCPMC10690587
OpenAlexW4388701618

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.